135 related articles for article (PubMed ID: 37114512)
21. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
[TBL] [Abstract][Full Text] [Related]
22. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
[TBL] [Abstract][Full Text] [Related]
23. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
[TBL] [Abstract][Full Text] [Related]
24. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.
Yamakawa K; Fujimi S; Mohri T; Matsuda H; Nakamori Y; Hirose T; Tasaki O; Ogura H; Kuwagata Y; Hamasaki T; Shimazu T
Crit Care; 2011; 15(3):R123. PubMed ID: 21569368
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.
Koga T; Inoue D; Okada A; Aramaki T; Yamasaki S; Nakashima M; Kawakami A; Eguchi K
Rheumatol Int; 2011 Dec; 31(12):1657-9. PubMed ID: 21240494
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction.
Hayakawa M; Kushimoto S; Watanabe E; Goto K; Suzuki Y; Kotani T; Kiguchi T; Yatabe T; Tagawa J; Komatsu F; Gando S
Thromb Haemost; 2017 May; 117(5):851-859. PubMed ID: 28229162
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetic analysis of thrombomodulin alfa to support dosing rationale in patients with renal impairment.
Mouksassi MS; Marier JF; Bax L; Osawa Y; Tsuruta K
Clin Pharmacol Drug Dev; 2015; 4(3):210-7. PubMed ID: 27140801
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
[TBL] [Abstract][Full Text] [Related]
29. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.
Tamura K; Saito H; Asakura H; Okamoto K; Tagawa J; Hayakawa T; Aoki N
Int J Clin Oncol; 2015 Aug; 20(4):821-8. PubMed ID: 25385713
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation.
Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N
Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
[TBL] [Abstract][Full Text] [Related]
33. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
Sasaki K; Okumura H; Uchikado Y; Minami K; Ijichi T; Owaki T; Ishigami S; Natsugoe S
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1213-5. PubMed ID: 24047782
[TBL] [Abstract][Full Text] [Related]
34. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
[TBL] [Abstract][Full Text] [Related]
35. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial.
Saito H; Maruyama I; Shimazaki S; Yamamoto Y; Aikawa N; Ohno R; Hirayama A; Matsuda T; Asakura H; Nakashima M; Aoki N
J Thromb Haemost; 2007 Jan; 5(1):31-41. PubMed ID: 17059423
[TBL] [Abstract][Full Text] [Related]
37. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.
Ito T; Thachil J; Asakura H; Levy JH; Iba T
Crit Care; 2019 Aug; 23(1):280. PubMed ID: 31416465
[TBL] [Abstract][Full Text] [Related]
38. Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation.
Shirahata A; Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kajiki M; Honda G; Sakata Y
Eur J Pediatr; 2014 Mar; 173(3):303-11. PubMed ID: 24005342
[TBL] [Abstract][Full Text] [Related]
39. The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis).
Mohri M; Gonda Y; Oka M; Aoki Y; Gomi K; Kiyota T; Sugihara T; Yamamoto S; Ishida T; Maruyama I
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):274-83. PubMed ID: 9282791
[TBL] [Abstract][Full Text] [Related]
40. Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation.
Kobayashi T; Kajiki M; Nihashi K; Honda G
Thromb Res; 2017 Nov; 159():109-115. PubMed ID: 29153952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
